The “PReCIOUS” project, presented by Transactiva under the 2014-2010 POR FESR 1.2.A.1 call for proposals, was admitted among the eligible projects, ranking third.
POR FESR: the PReCIOUS project approved for funding

The “PReCIOUS” project, presented by Transactiva under the 2014-2010 POR FESR 1.2.A.1 call for proposals, was admitted among the eligible projects, ranking third.
On June 5th, a delegation of Biotechnology students from the University of Milan had the chance to visit the “Luigi Danieli” Science and Technology Park in Udine, with the opportunity to better understand both our company and the resources offered
On March 19, 2018 the “Dialogo sulle politiche di coesione” (local and regional dialogues on cohesion policy) event, organized by AICCRE (Italian Association for the Council of Municipalities and Regions of Europe) took place in Udine, at the Salone del
On thursday, 15 february 2018 the 4th project meeting brought together the protagonists of the oraCle project to review and discuss the work progress. The meeting begun in the morning at the University of Udine, where each project partner presented
On 29th and 30th January 2018 two members of the Advisory Council of the ICCO (Italian Chamber of Commerce in Ontario) – Tenio EVANGELISTA of the Omers Venture (Investment sector) and Renato DISCENZA of the Azcendis (Life science / health
The local and national press is talking about “oraCle: New integrated approach for the oral therapy of Crohn’s disease”. Many journals are spreading awareness towards this project. Here the press releases issued in the month of January, 2018. Diario di
On Friday, 17th November 2017 Transactiva’s staff took part in the conference “GDPR. Data security. Corporate secret.” held at PST “Luigi Danieli”, organized by Fill In The Blanks srl and in collaboration with D’Agostini Law Firm. On the occasion Transactiva
Transactiva and the University of Trieste were among the winners of the “Made in Trieste” call, aimed at promoting applied research projects in the field of Life Sciences, with the project “Production of human Brain-Derived Neurotrophic Factor (BDNF) in endosperm of
The oraCle project is at the height of its activities. The scientific partners met at the University of Trieste, guests of the Department of Life Sciences, on October 12, 2017. For the purposes of a better and more effective sharing
The oraCle project is proceeding well. The project partners met in the second meeting, held on 19 June 2017 at the Biofarma SpA headquarters. The meeting, focused on the scientific side of oraCle, saw a useful confrontation on the technical aspects